Athanor Capital, LP Corcept Therapeutics Inc Transaction History

Athanor Capital, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$19.97 - $24.43 $1.12 Million - $1.37 Million	-55,920 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$23.49 - $30.56 $905,492 - $1.18 Million	38,548 Added 221.9%	55,920 $1.33 Million
Q4 2020 Feb 16, 2021	SELL	$16.78 - $27.3 $381,979 - $621,457	-22,764 Reduced 56.72%	17,372 $454,000
Q3 2020 Nov 16, 2020	BUY	$12.46 - $19.98 $152,522 - $244,575	12,241 Added 43.88%	40,136 $699,000
Q2 2020 Aug 13, 2020	BUY	$11.0 - $18.26 $306,845 - $509,362	27,895 New	27,895 $469,000

347

86.6M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.16B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Athanor Capital, LP with notifications on news.